Rosemere Cancer Centre at Royal Preston Hospital
Preston, England, United Kingdom
Charity in Fulwood, England
Sharoe Green Ln, Fulwood, Preston PR2 9HT
About Rosemere Cancer Centre at Royal Preston Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Rosemere Cancer Centre at Royal Preston Hospital
During the past decade, Rosemere Cancer Centre at Royal Preston Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
2012-07-01
2013-05-01
Completed
354
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rosemere Cancer Centre at Royal Preston Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials
sponsored, "University College, London" with 3 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "Cardiff University"
with 1 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rosemere Cancer Centre at Royal Preston Hospital"
#1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Velindre NHS Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Rosemere Cancer Centre at Royal Preston Hospital
According to Clinical.Site data, the most researched conditions in "Rosemere Cancer Centre at Royal Preston Hospital" are
"Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Extragonadal Germ Cell Tumor" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Rosemere Cancer Centre at Royal Preston Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Rosemere Cancer Centre at Royal Preston Hospital
Most popular intervention types in "Rosemere Cancer Centre at Royal Preston Hospital" are "Drug" (14 trials), "Biological" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "adjuvant therapy" (3 trials), "carboplatin" (3 trials), "neoadjuvant therapy" (3 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Rosemere Cancer Centre at Royal Preston Hospital
The vast majority of trials in "Rosemere Cancer Centre at Royal Preston Hospital" are
12 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Rosemere Cancer Centre at Royal Preston Hospital
Currently, there are NaN active trials in "Rosemere Cancer Centre at Royal Preston Hospital".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Rosemere Cancer Centre at Royal Preston Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rosemere Cancer Centre at Royal Preston Hospital, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".